Last reviewed · How we verify

NCT06230003

Efficacy of Erector Spinae Plane (ESP) Block in Patients With Inflammatory Bowel Disease (IBD)

Completed NA Last updated 8 May 2025
What this trial tests

NA trial testing Ropivacaine in Opioid Use in 67 participants. Completed in 1 March 2025.

Timeline
21 July 2021
Primary endpoint
17 December 2024
1 March 2025

Quick facts

Lead sponsorSamuel Lunenfeld Research Institute, Mount Sinai Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment67
Start date21 July 2021
Primary completion17 December 2024
Estimated completion1 March 2025
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

Samuel Lunenfeld Research Institute, Mount Sinai Hospital

Who can join

Adults 18 to 85, any sex, with Opioid Use. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This will be a prospective, double-blind randomized controlled clinical trial. There will be two arms of treatment: intervention and control group. Preoperatively patients will be allocated at random to receive ultrasound guided bilateral ESP block either with the local anesthetic (intervention group) normal saline (control group). The aim of this study is to examine the effect of ESP block to increase the Quality of Recovery (measured via QoR-15 total score) and decrease opioid consumption.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Ropivacaine

Trials testing the same drug.

Other recruiting trials for Opioid Use

Currently open trials in the same condition.

Other Samuel Lunenfeld Research Institute, Mount Sinai Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06230003.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing